Why Jim Cramer Is Bullish on Johnson & Johnson Shares - TheStreet

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson (JNJ) shares for a few reasons:

it has a triple-A balance sheet
there are multiple drugs in the pipeline
it's still incredibility well run by Alex Gorsky

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Investing Emerging Markets Consumer Staples Jim Cramer Video

More from Video

Jim Cramer explains why he thinks Canopy Growth Corp. is the one cannabis stock that still looks investable.

Jim Cramer

Sep 22, 2018 1:20 PM EDT

Did you know that the majority of closed-end funds or CEF's are fixed-income (tax-exempt bond funds make up 42% of the market and domestic taxable bond funds make up 20%) and the majority of CEFs also have leverage?

Robert Powell

Sep 22, 2018 11:37 AM EDT

Cancer affects all of us. But the Damon Runyon Cancer Research Foundation has invested $330 million (and counting) in research to fight it. We spent time with its first female CEO to hear about her journey and how immunotherapies are taking the lead.

Tracy Byrnes

Sep 21, 2018 4:55 PM EDT

What does potential inflation build mean for the grain markets?

CME Group

Sep 21, 2018 4:30 PM EDT

We hit the street and asked some pros their views of the current market, tariffs, rising interest rates and more. Watch now!

Tracy Byrnes

Sep 21, 2018 4:20 PM EDT

Watchlist

- Jim Cramer
- Investing
  - Options
  - ETFs
  - Bitcoin
  - Earnings
  - Fixed Income
  - Stocks
  - Futures
  - Funds
- Personal Finance
  - Mortgages
  - Education
  - Real Estate
  - Savings
  - Insurance
  - Credit Cards
  - Taxes
  - Debt Management
- Retirement
- Technology
  - Cybersecurity
- Markets
- How-To
- Video
  - Audio
Privacy Policy|Terms of Use
© 1996-2018 TheStreet Inc. All rights reserved